Partner Interview
Published July 1, 2025
Coloplast: Ostomy Competitive & Market Dynamics
inpractise.com/articles/coloplast-ostomy-competitive-and-market-dynamics
Executive Bio
Former Ostomy Executive at ConvaTec
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
That's somewhat reassuring or informative. Even with your detailed market analysis and better vantage point, you didn't arrive at a different result. From the outside, it seems there are a few factors that might not apply to the entire market but still drive individual company results. As I understand it, compliance plays a role. How many patients actually use all the products they are reimbursed for? Innovation is another factor. It's not like-for-like pricing, but introducing new products can lead to price increases. Upselling accessories is something the company also highlights. What do you make of the impact of these factors on growth?
We were able to track longitudinal data, meaning we could see individual patients' purchasing patterns over time and how much product they were buying. This allowed us to track product utilization. Generally, there was good compliance. I say "generally good compliance" because the main concern is the 1% of the time when the product fails. 99% of the time, the products work fine. However, the 1% failure is devastating and traumatic.
This is a snippet of the transcript.to get full access.
That's somewhat reassuring or informative. Even with your detailed market analysis and better vantage point, you didn't arrive at a different result. From the outside, it seems there are a few factors that might not apply to the entire market but still drive individual company results. As I understand it, compliance plays a role. How many patients actually use all the products they are reimbursed for? Innovation is another factor. It's not like-for-like pricing, but introducing new products can lead to price increases. Upselling accessories is something the company also highlights. What do you make of the impact of these factors on growth?
We observed interesting behavior. At home, people might use the bag for longer periods because they are comfortable. But when they go out, they change it frequently to avoid failure during dinner, outings, or vacations. Consumer surveys showed that, for example, with a one-piece system in Europe, people might wear it for one and a half days. However, if going out for dinner, they replace it in the afternoon to ensure no failure. On vacation, utilization might be higher to avoid ruining the experience.
This is a snippet of the transcript.to get full access.
That's somewhat reassuring or informative. Even with your detailed market analysis and better vantage point, you didn't arrive at a different result. From the outside, it seems there are a few factors that might not apply to the entire market but still drive individual company results. As I understand it, compliance plays a role. How many patients actually use all the products they are reimbursed for? Innovation is another factor. It's not like-for-like pricing, but introducing new products can lead to price increases. Upselling accessories is something the company also highlights. What do you make of the impact of these factors on growth?
Compliance was generally good, and people weren't hoarding bags. If reimbursement allowed for 12 bags a month, people used about 12 on average, maybe 10 some months, maybe 14 others, but it averaged out.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content

Coloplast: Urology Segment & China Market
Former Director at Coloplast

Coloplast: Reimbursements, Innovation & Local Operations
Former General Manager at Coloplast

Intuitive Surgical & Surgical Science: Robotic Simulation & Digital Ecosystem
Former VP at Intuitive Surgical

Intuitive Surgical: Competitive Threat of Instrument Remanufacturing
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.